Biologic therapies in rheumatic diseases: drug and anti-drug antibody levels and clinical efficacy

Stefania Lombardi,Cristina Bernardoni,Daniela Bertolucci,Riccardo Cecchetti,Francesca De Giorgio,GianLuigi Occhipinti,Andrea Palagi,Gloria Bertacca,Isabella Giannelli,Elena Bonomi,Marco Friggeri,Giancarlo Tartarelli

Biologic therapies in rheumatic diseases: drug and anti-drug antibody levels and clinical efficacy

2017

Stefania Lombardi
Cristina Bernardoni
Daniela Bertolucci
Riccardo Cecchetti
Francesca De Giorgio
GianLuigi Occhipinti
Andrea Palagi
Gloria Bertacca
Isabella Giannelli
Elena Bonomi
Marco Friggeri
Giancarlo Tartarelli

Abstract Background: The aim of this study was to evaluate the relevance of drug and anti-drug antibody detection in the clinical management of patients with rheumatoid arthritis (RA) and spondyloarthropaties (SpA) in

Keywords:

Drug
Antibody
Rheumatoid arthritis
Pharmacology
Immunology
Anti-Drug Antibody
Medicine
antibody detection
clinical efficacy
drug levels
biologic therapies

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations